TNFRSF11B and breast carcinoma: Women who developed breast cancer had significantly lower mean baseline OPG concentrations (90.59 pg/ml [range 4.2–205.7 pg/ml]) compared to the OPG concentrations of women who did not develop breast cancer (117.9 pg/ml [7.4–547.7]) (P = 0.04).